Tianjin Medical University Cancer Institute and Hospital (TMUCIH)
Tianjin Medical University Cancer Institute and Hospital (TMUCIH) — Tianjin
Hospital Profile
Tianjin Medical University Cancer Institute and Hospital (Tianjin Cancer Hospital) is the birthplace of oncology disciplines in China. It is a top-tier (Grade 3, Class A) specialized cancer hospital integrating medical treatment, education, research, and prevention, and one of the first national clinical research centers for malignant tumors. The oncology discipline is a national key discipline and entered the national "Double First-Class" discipline construction list in 2017. The hospital has four national clinical key specialties (thoracic surgery, nursing, oncology, pathology) and four municipal clinical diagnosis and treatment research centers. It brings together numerous high-level national talents, including academicians of the Chinese Academy of Engineering and Changjiang Scholars. The hospital has three provincial and ministerial key laboratories, two Ministry of Education innovation teams, serves as the headquarters for the Chinese Anti-Cancer Association, and publishes the national first-level core journal "Chinese Clinical Oncology." It has received multiple honors, including the National Civilized Unit.
Medical Milestones
In 1861, the British Army established a military hospital (its predecessor); in 1952, Professor Jin Xianzai founded the first oncology department in the People's Republic of China; starting in 1954, nationwide training courses for clinical and pathology physicians in oncology were established; in 1986, it was named Tianjin Tumor Hospital; in 1987, it moved to its current location; in 1997, it became the Affiliated Tumor Hospital of Tianjin Medical University; in 2005, it was approved as a national continuing medical education base; in 2017, it was selected for the national reserve list of projects for improving the diagnosis and treatment of difficult diseases and included in the national 'Double First-Class' construction initiative.
Key Capabilities & Patient Care
There are 46 clinical medical and technical departments and 12 basic research departments, covering a complete range of diseases. It has obvious characteristics and advantages in the diagnosis and treatment of breast cancer, lung cancer, liver cancer, gastric cancer, colorectal cancer, esophageal cancer, bone and soft tissue tumors, head and neck tumors, genitourinary tumors, and hematologic and lymphatic system tumors, and is renowned both domestically and internationally for its surgical technical expertise. As an affiliate unit of the Tianjin Clinical/Nursing/Oncological Disease Quality Control Center, it continuously improves diagnostic and treatment standards and service quality.
Advanced Technology
The hospital covers an area of 69,000 square meters, with a building area of 175,000 square meters. It is equipped with 120 sets of medical devices worth over one million yuan each, including the Da Vinci surgical robot, CyberKnife, PET-CT, medical linear accelerator, MRI, and DSA (total equipment value of 760 million yuan). It has a postdoctoral research workstation and a national clinical drug trial institution. Statistics: • Bed capacity: over 2,300 beds (2023) • Total staff: 2,867 registered personnel (2023) • Inpatients: 215,000 discharges (2023) • Outpatient and emergency visits: 1.61 million (2023) • Inpatient and elective surgeries: 53,000 cases (2023) • Number of senior physicians: Official total not disclosed; estimated approximately 344–459 people (this is an estimate, not official data, calculated as 2,867 staff × 12%–16%)
International Patient Services
Established sister hospital relationships with the MD Anderson Cancer Center and Moffitt Cancer Center in the United States, and has established close cooperation with medical and research institutions in nearly 30 countries and regions; it is a member of the WHO International Association of Cancer Registries (IACR), one of the WHO cancer registry centers, a member of the Union for International Cancer Control (UICC), and the location of the UICC China liaison office. (No specific services of an independent special needs department/international department are mentioned)